Video Latest - ecancer

Editor’s Choice for October 2018

Prof Gordon McVie - Founding Editor, ecancer

1 Nov 2018

The IMpower-132 trial for non small cell lung cancer

Dr Vassiliki Papadimitrakopoulou - University of Texas MD Anderson Cancer Center, Houston, US

29 Oct 2018

Latest advances in treatment for ALK positive NSCLC

Prof Gordon McVie, Dr Lázaro Quintela

26 Oct 2018

The case for biosimilars

Dr Hans-Christian Kolberg - Marienhospital, Bottrop, Germany

26 Oct 2018

Highlights in early non-metastatic NSCLC and thoracic tumours

Dr Enriqueta Felip - Vall d'Hebron University Hospital (VHIO), Barcelona, Spain

26 Oct 2018

Highlights in SCLC from ESMO 2018

Dr Noemi Reguart - University of Barcelona, Barcelona, Spain

26 Oct 2018

Safety analysis of entrectinib for NTRK fusion tumours

Dr George D. Demetri - Harvard Cancer Center, Boston, USA

26 Oct 2018

CheckMate142: Checkpoint combination therapy in first-line colorectal cancer

Dr Heinz-Josef J. Lenz - Keck School of Medicine of USC, Los Angeles, USA

26 Oct 2018

SOLO1: Maintenance olaparib in advanced BRCA ovarian cancer

Dr Kathleen N. Moore - The Stephenson Cancer Center, Oklahoma City, USA

26 Oct 2018

Lung highlights from ESMO 2018

Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy

26 Oct 2018

Erlotinib for neoadjuvant treatment of EGFR NSCLC

Dr Wen-Zhao Zhong - Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China

26 Oct 2018

AURA 3: Mechanisms of osimertinib resistance in patients with EGFR T790M advanced NSCLC

Dr Vassiliki A. Papadimitrakopoulou - University of Texas MD Anderson Cancer Center, Houston, USA

25 Oct 2018

Video